Novel platform for automation of high throughput drug discovery using patient derived colorectal cancer organoids

被引：1
|
作者：
Lim, Angeline
Tong, Zhisong
Macha, Prathyushakrishna
Sirenkp, Oksana
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-199
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
199
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Metastasis mouse model using patient derived from colorectal cancer organoids
    Okamoto, Takuya
    Yao, Ryoji
    Yaginuma, Katsuyuki
    Nagayama, Satoshi
    CANCER SCIENCE, 2018, 109 : 1365 - 1365
  • [22] The application of pancreatic cancer organoids for novel drug discovery
    Melzer, Michael Karl
    Resheq, Yazid
    Navaee, Fatemeh
    Kleger, Alexander
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (04) : 429 - 444
  • [23] High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
    Higa, Arisa
    Takahashi, Nobuhiko
    Hiyama, Gen
    Tamura, Hirosumi
    Hoshi, Hirotaka
    Shimomura, Kenju
    Watanabe, Shinya
    Takagi, Motoki
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (172):
  • [24] Tailored chemotherapy for colorectal cancer peritoneal metastases based on a drug-screening platform in patient-derived organoids: a case report
    Prieto, Isabel
    Barbachano, Antonio
    Rodriguez-Salas, Nuria
    Vinal, David
    Cortes-Guiral, Delia
    Munoz, Alberto
    Fernandez-Barral, Asuncion
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (01) : 442 - 449
  • [25] HTPS flow cytometry: A novel platform for automated high throughput drug discovery and characterization
    Edwards, BS
    Kuckuck, FW
    Prossnitz, ER
    Ransom, JT
    Sklar, LA
    JOURNAL OF BIOMOLECULAR SCREENING, 2001, 6 (02) : 83 - 90
  • [26] Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
    Lisi Zeng
    Quanxing Liao
    Haoran Zhao
    Shengwei Jiang
    Xianzi Yang
    Hongsheng Tang
    Qingjun He
    Xiansheng Yang
    Shuxian Fang
    Jinfu He
    Weiwen Cui
    Laiqiang Huang
    Shaohua Ma
    Shuzhong Cui
    Cancer Biology & Medicine, 2021, 18 (03) : 750 - 762
  • [27] Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
    Zeng, Lisi
    Liao, Quanxing
    Zhao, Quanxing
    Jiang, Shengwei
    Yang, Xianzi
    Tang, Hongsheng
    He, Qingjun
    Yang, Xiansheng
    Fang, Shuxian
    He, Jinfu
    Cui, Weiwen
    Huang, Laiqiang
    Ma, Shaohua
    Cui, Shuzhong
    CANCER BIOLOGY & MEDICINE, 2021, 18 (03) : 750 - +
  • [28] Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
    Lisi Zeng
    Quanxing Liao
    Haoran Zhao
    Shengwei Jiang
    Xianzi Yang
    Hongsheng Tang
    Qingjun He
    Xiansheng Yang
    Shuxian Fang
    Jinfu He
    Weiwen Cui
    Laiqiang Huang
    Shaohua Ma
    Shuzhong Cui
    Cancer Biology & Medicine , 2021, (03) : 750 - 762
  • [29] Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening
    Verissimo, Carla S.
    Overmeer, Rene M.
    Ponsioen, Bas
    Drost, Jarno
    Mertens, Sander
    Verlaan-Klink, Ingrid
    van Gerwen, Bastiaan
    van der Ven, Marieke
    van de Wetering, Marc
    Egan, David A.
    Bernards, Rene
    Clevers, Hans
    Bos, Johannes L.
    Snippert, Hugo J.
    eLife, 2016, 5
  • [30] Patient-derived organoids to model intra- and intertumoral heterogeneity of pancreatic cancer in high-throughput drug screens
    Kamyabi-Moghaddam, Z.
    Wirth, M.
    Babucke, M.
    Blume, K.
    Saur, D.
    Schorn, S.
    Martignoni, M. E.
    Ceyhan, G.
    Schmid, R. M.
    Siveke, J. T.
    Schneider, G.
    Reichert, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 162 - 162
12345